This clinical trial compares usual care to interpersonal communication training and vaccination workflow training, alone or in combination, for improving commu…

Human Papillomavirus-Related Carcinoma

~Estimated

~$10 – $6,250

Fred Hutchinson Cancer CenterNCT06926062

Phase 1

A Dose Escalation Phase I Trial of the Safety and Immunogenicity of RG1-VLP, A Candidate Broadly Protective Vaccine for the Prevention of HPV-Associated Cancer

This phase I trial tests the safety, side effects, and best dose of RG1-virus-like particle (VLP) in preventing human papillomavirus (HPV)-related cancers in w…

Human Papillomavirus-Related Carcinoma

~Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT05985681

Observational

TweenVax: A Comprehensive Practice-, Provider-, and Parent/Patient-Level Intervention to Improve Adolescent HPV Vaccination

This clinical trial compares the effect of a vaccine promotional intervention, TweenVax, to standard of care vaccination promotion practices on rates of human …

Human Papillomavirus-Related Carcinoma

~Estimated

~$10 – $6,250

Emory UniversityNCT07104240